J R Redman

2.5k total citations
34 papers, 2.1k citations indexed

About

J R Redman is a scholar working on Pathology and Forensic Medicine, Genetics and Neurology. According to data from OpenAlex, J R Redman has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 17 papers in Genetics and 7 papers in Neurology. Recurrent topics in J R Redman's work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (12 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). J R Redman is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (12 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). J R Redman collaborates with scholars based in United States. J R Redman's co-authors include Fernando Cabanillas, William S. Velasquez, Moshe Talpaz, Peter McLaughlin, William Plunkett, F Swan, Fredrick B. Hagemeister, Charles Koller, Maria Alma Rodriguez and Hagop M. Kantarjian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

J R Redman

34 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J R Redman United States 24 1.2k 1.1k 662 436 315 34 2.1k
Maura Brugiatelli Italy 23 1.5k 1.3× 967 0.9× 862 1.3× 449 1.0× 271 0.9× 92 2.0k
Teodoro Chisesi Italy 17 972 0.8× 552 0.5× 580 0.9× 414 0.9× 189 0.6× 89 1.4k
Y Bastion France 23 2.5k 2.1× 1.2k 1.1× 1.6k 2.5× 532 1.2× 373 1.2× 47 3.2k
DC Linch United Kingdom 19 949 0.8× 397 0.4× 720 1.1× 241 0.6× 229 0.7× 37 1.5k
H Tilly France 16 1.3k 1.1× 674 0.6× 856 1.3× 224 0.5× 460 1.5× 44 2.0k
William S. Velasquez United States 29 2.5k 2.1× 1.3k 1.3× 1.4k 2.1× 487 1.1× 459 1.5× 58 3.5k
Anne Lennard United Kingdom 20 831 0.7× 562 0.5× 561 0.8× 240 0.6× 414 1.3× 51 1.6k
Meyer R. Heyman United States 14 1.4k 1.2× 924 0.9× 1.1k 1.7× 699 1.6× 436 1.4× 22 2.8k
Anne Sonet Belgium 22 1.3k 1.1× 589 0.6× 873 1.3× 396 0.9× 265 0.8× 64 2.2k
L Resegotti Italy 23 695 0.6× 622 0.6× 624 0.9× 271 0.6× 807 2.6× 93 1.8k

Countries citing papers authored by J R Redman

Since Specialization
Citations

This map shows the geographic impact of J R Redman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J R Redman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J R Redman more than expected).

Fields of papers citing papers by J R Redman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J R Redman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J R Redman. The network helps show where J R Redman may publish in the future.

Co-authorship network of co-authors of J R Redman

This figure shows the co-authorship network connecting the top 25 collaborators of J R Redman. A scholar is included among the top collaborators of J R Redman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J R Redman. J R Redman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Duvic, Madeleine, Noreen A. Lemak, J R Redman, et al.. (1996). Combined modality therapy for cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology. 34(6). 1022–1029. 81 indexed citations
3.
Feman, Stephen S., et al.. (1996). The Vanderbilt Classification System in the evaluation of diabetic retinopathy patients treated with Alredase.. PubMed. 94. 433–47; discussion 447. 2 indexed citations
4.
Swan, F, Susan L. Tucker, Herbert A. Fritsche, et al.. (1995). Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase. Leukemia & lymphoma. 18(1-2). 87–92. 18 indexed citations
5.
McLaughlin, Peter, Fredrick B. Hagemeister, F Swan, et al.. (1994). Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.. Journal of Clinical Oncology. 12(3). 575–579. 77 indexed citations
6.
McLaughlin, Peter, Fernando Cabanillas, Fredrick B. Hagemeister, et al.. (1993). CHOP-Bleo plus interferon for stage IV low-grade lymphoma. Annals of Oncology. 4(3). 205–211. 46 indexed citations
7.
Redman, J R, Fernando Cabanillas, W S Velasquez, et al.. (1992). Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.. Journal of Clinical Oncology. 10(5). 790–794. 173 indexed citations
8.
Spinolo, Jorge A., Fernando Cabanillas, S Khorana, et al.. (1992). Therapy of relapsed or refractory low-grade follicular lymphomas: Factors associated with complete remission, survival and time to treatment failure. Annals of Oncology. 3(3). 227–232. 23 indexed citations
9.
Straus, David J., Joachim Yahalom, Jeffrey J. Gaynor, et al.. (1992). Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease. Cancer. 69(4). 1052–1060. 23 indexed citations
10.
Robertson, L. E., J R Redman, James J. Butler, et al.. (1991). Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.. Journal of Clinical Oncology. 9(2). 236–242. 57 indexed citations
11.
Hagemeister, Fredrick B., Lillian M. Fuller, William S. Velasquez, et al.. (1991). Two cycles of MOPP and radiotherapy: Effective treatment for stage IIIA and IIIB Hodgkin's disease. Annals of Oncology. 2(1). 25–31. 7 indexed citations
12.
Keating, Michael J., Hagop M. Kantarjian, & J R Redman. (1990). Fludarabine treatment of chronic lymphocytic leukemia and indolent lymphomas. 42(3). 136–144. 1 indexed citations
13.
Hagemeister, Fredrick B., Peter McLaughlin, W S Velasquez, et al.. (1990). Small noncleaved cell lymphoma in adults: superior results for stages I-III disease.. Journal of Clinical Oncology. 8(4). 615–622. 52 indexed citations
14.
Swan, F, William S. Velasquez, S. C. Tucker, et al.. (1989). A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.. Journal of Clinical Oncology. 7(10). 1518–1527. 128 indexed citations
15.
McLaughlin, Peter, W S Velasquez, J R Redman, et al.. (1988). Chemotherapy With Dexamethasone, High-Dose Cytarabine, and Cisplatin for Parenchymal Brain Lymphoma. JNCI Journal of the National Cancer Institute. 80(17). 1408–1412. 27 indexed citations
16.
Redman, J R, Daiva Bajorunas, George Y. Wong, et al.. (1988). Bone mineralization in women following successful treatment of Hodgkin's disease. The American Journal of Medicine. 85(1). 65–72. 40 indexed citations
17.
Cabanillas, Fernando, William S. Velasquez, Peter McLaughlin, et al.. (1988). Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.. PubMed. 25(2 Suppl 2). 47–50. 57 indexed citations
18.
Keating, Michael J., Hagop M. Kantarjian, Moshe Talpaz, J R Redman, & K. B. McCredie. (1988). Fludarabine therapy in chronic lymphocytic leukemia (CLL).. PubMed. 30(5-6). 461–6. 23 indexed citations
19.
Redman, J R, Gina R. Petroni, Patricia E. Saigo, Nancy L. Geller, & T. Hakes. (1986). Prognostic factors in advanced ovarian carcinoma.. Journal of Clinical Oncology. 4(4). 515–523. 121 indexed citations
20.
Redman, J R, Davor Vugrin, Z Arlin, et al.. (1984). Leukemia following treatment of germ cell tumors in men.. Journal of Clinical Oncology. 2(10). 1080–1087. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maura Brugiatelli Breakdown of academic impact, for papers by Teodoro Chisesi Breakdown of academic impact, for papers by Y Bastion Breakdown of academic impact, for papers by DC Linch Breakdown of academic impact, for papers by H Tilly Breakdown of academic impact, for papers by William S. Velasquez Breakdown of academic impact, for papers by Anne Lennard Breakdown of academic impact, for papers by Meyer R. Heyman Breakdown of academic impact, for papers by Anne Sonet Breakdown of academic impact, for papers by L Resegotti
Rankless by CCL
2026